The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Celgene; Janssen; Roche
Speakers' Bureau - Janssen
Research Funding - Janssen
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - Janssen; Roche
Acalabrutinib monotherapy in patients (pts) with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
 
Martin JS Dyer
No Relationships to Disclose
 
Sven De Vos
No Relationships to Disclose
 
Jia Ruan
Honoraria - Acerta Pharma; Celgene; Janssen Research & Development; Seagen
Consulting or Advisory Role - Acerta Pharma; Janssen Research & Development; Seagen
Research Funding - Acerta Pharma; Celgene; Pharmacyclics; Seagen
 
Christopher Flowers
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Celgene; Denovo Biopharma; Gilead Sciences; Karyopharm Therapeutics; OptumRx; Pharmacyclics/Janssen; Seagen; Spectrum Pharmaceuticals
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Celgene (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immune Design (Inst); Infinity Pharmaceuticals (Inst); Janssen Oncology (Inst); Onyx (Inst); Pharmacyclics (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche; Gilead Sciences
 
Kami J. Maddocks
Honoraria - Bristol-Myers Squibb; Janssen; Pharmacyclics; Seagen
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen; Pharmacyclics; Seagen
Research Funding - Merck; Pharmacyclics
 
Simon Rule
No Relationships to Disclose
 
Ahmed M. Hamdy
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
 
Raquel Izumi
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Consulting or Advisory Role - Trigemina
Patents, Royalties, Other Intellectual Property - Patents pending for Acerta Pharma
 
J. Greg Slatter
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
 
Jean Cheung
Employment - Acerta Pharma
Stock and Other Ownership Interests - Acerta Pharma
Travel, Accommodations, Expenses - Acerta Pharma
 
Melanie M. Frigualt
Employment - Acerta Pharma; AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - AstraZeneca
 
Helen Wei
Employment - Acerta Pharma
 
Sanchita Mourya
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca
 
Naomi N. H. Hunder
Employment - Acerta Pharma; Seagen
Stock and Other Ownership Interests - AstraZeneca; Seagen
 
Nathan Hale Fowler
Consulting or Advisory Role - Abbvie; Celgene; Merck; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche